Literature DB >> 33457413

Erratum to "miR-876 Inhibits EMT and Liver Fibrosis via POSTN to Suppress Metastasis in Hepatocellular Carcinoma".

Kai Chen1,2, Zhonghu Li3, Mengyun Zhang4, Bo Wang3, Tao Peng5, Yanbing Shen3, Jianxin Zhang3, Jiaxin Ye3, Yu Liu2, Di Tang3, Minjie Peng6, Dandan Ma3, Zhengkang Xiao3, Yujun Zhang1, Weidong Jin3, Xiaowu Li1,6.   

Abstract

[This corrects the article DOI: 10.1155/2020/1964219.].
Copyright © 2020 Kai Chen et al.

Entities:  

Year:  2020        PMID: 33457413      PMCID: PMC7787729          DOI: 10.1155/2020/7043985

Source DB:  PubMed          Journal:  Biomed Res Int            Impact factor:   3.411


  1 in total

1.  miR-876 Inhibits EMT and Liver Fibrosis via POSTN to Suppress Metastasis in Hepatocellular Carcinoma.

Authors:  Kai Chen; Zhonghu Li; Mengyun Zhang; Bo Wang; Tao Peng; Yanbing Shen; Jianxin Zhang; Jiaxin Ye; Yu Liu; Di Tang; Minjie Peng; Dandan Ma; Zhengkang Xiao; Yujun Zhang; Weidong Jin; Xiaowu Li
Journal:  Biomed Res Int       Date:  2020-10-05       Impact factor: 3.411

  1 in total
  1 in total

1.  Periostin promotes the proliferation and metastasis of osteosarcoma by increasing cell survival and activates the PI3K/Akt pathway.

Authors:  Chaojian Xu; Ziyue Wang; Long Zhang; Yi Feng; Jia Lv; Zhuangzhuang Wu; Rong Yang; Taiyong Wu; Jian Li; Ruhao Zhou; Zhi Tian; Junjun Bai; Huadong Zhang; Yanping Lan; Zhi Lv
Journal:  Cancer Cell Int       Date:  2022-01-20       Impact factor: 5.722

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.